What Happened?
Shares of health and wellness products company Herbalife (NYSE: HLF) jumped 8.5% in the morning session after Mizuho analysts raised their price target on the stock. The firm increased its price objective to $10.00 from $9.00, while maintaining a "Neutral" rating on the shares. This more optimistic price outlook comes amid positive signs for the supplement market.
A recent survey conducted by Herbalife revealed that four out of five people in the Asia-Pacific region take health supplements regularly, indicating growing popularity. This data, gathered from 9,000 respondents across 11 markets, suggests strong consumer interest in preventive health products. The sentiment from Mizuho adds to a generally favorable view from the analyst community, with a consensus "Buy" rating reported as of August 28.
Is now the time to buy Herbalife? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Herbalife’s shares are extremely volatile and have had 33 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 10 days ago when the stock gained 7.2% on the news that the company shared positive preliminary results from the beta launch of its new Pro2col digital health and wellness platform.
This positive development builds on momentum from the company's recent second-quarter earnings report, where it beat expectations and raised its full-year sales guidance. Herbalife revealed that its new Pro2col health and wellness digital platform, acquired in March, has seen strong engagement in its beta phase, with over 7,000 distributors participating since July.
The platform collects detailed user data, from nutritional goals to sleep quality, which the company intends to use to suggest targeted products, boost sales, and improve customer retention. Herbalife plans a full commercial release of the platform in the U.S. and Puerto Rico during the fourth quarter of 2025, with further international expansion planned for 2026.
Herbalife is up 45.1% since the beginning of the year, but at $9.70 per share, it is still trading 10.5% below its 52-week high of $10.83 from July 2025. Investors who bought $1,000 worth of Herbalife’s shares 5 years ago would now be looking at an investment worth $197.25.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
